"O CECAN, Centro Avançado de Oncologia, é uma unidade ambulatorial de diagnóstico e tratamento que sedia setores de radioterapia, quimioterapia e medicina nuclear, além de abrigar consultórios de várias especialidades, como mastologia, urologia, oncologia clínica, gastroenterologia, proctologia e cardiologia. O setor de diagnóstico por imagem da unidade é completamente aparelhado para a realização de diversos procedimentos, como tomografia computadorizada, ultrassonografia, mamografia, densitometria óssea e ressonância magnética."

During the past decade, Liga Norte Riograndense Contra O Cancer conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 12 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 10 clinical trials were completed. i.e. 35.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Liga Norte Riograndense Contra O Cancer" #1 sponsor was "Janssen Research & Development, LLC" with 21 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "Amgen" with 2 trials sponsored, "Bayer" with 2 trials sponsored and "Latin American Cooperative Oncology Group" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Liga Norte Riograndense Contra O Cancer" #1 collaborator was "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator, "Bayer AG (Sponsor)" with 1 trials as a collaborator, "Bracco (Sponsor)" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "CIMAB (Cuba)" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Liga Norte Riograndense Contra O Cancer" are "Multiple Myeloma" (7 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Breast Cancer" (3 trials), "Prostatic Neoplasms" (3 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "Liga Norte Riograndense Contra O Cancer" in a lesser frequency.

Most popular intervention types in "Liga Norte Riograndense Contra O Cancer" are "Drug" (42 trials), "Other" (5 trials), "Biological" (4 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Daratumumab" (5 trials), "Dexamethasone" (5 trials), "Bortezomib" (4 trials) and "Carboplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Liga Norte Riograndense Contra O Cancer" are 35 trials for "All" genders, 8 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Liga Norte Riograndense Contra O Cancer". undefined are not yet recruiting, 20 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Liga Norte Riograndense Contra O Cancer, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Liga Norte Riograndense Contra O Cancer, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Liga Norte Riograndense Contra O Cancer has several departments that took part in Clinical trials: "Centro de Pesquisa Clínica da Liga Norte Riograndense Contra o Câncer" - 2 trials